These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34721444)

  • 21. HLA in transplantation.
    Montgomery RA; Tatapudi VS; Leffell MS; Zachary AA
    Nat Rev Nephrol; 2018 Sep; 14(9):558-570. PubMed ID: 29985463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Desensitization for prevention of chronic antibody-mediated rejection after kidney transplantation.
    Tanabe K; Inui M
    Clin Transplant; 2013; 27 Suppl 26():2-8. PubMed ID: 24299229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization.
    Choi AY; Manook M; Olaso D; Ezekian B; Park J; Freischlag K; Jackson A; Knechtle S; Kwun J
    Front Immunol; 2021; 12():694763. PubMed ID: 34177960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor-specific anti-HLA antibody monitoring and removal in solid organ transplant recipients.
    Everly MJ
    Clin Transpl; 2011; ():319-25. PubMed ID: 22755425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HLA-incompatibility and kidney transplant: a question of desensitization].
    Grosjean F
    G Ital Nefrol; 2011; 28(6):581. PubMed ID: 22167608
    [No Abstract]   [Full Text] [Related]  

  • 26. Desensitization in the Setting of HLA-Incompatible Kidney Transplant.
    Malvezzi P; Jouve T; Noble J; Rostaing L
    Exp Clin Transplant; 2018 Aug; 16(4):367-375. PubMed ID: 29863455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Desensitization for sensitized patients awaiting heart transplant.
    Byku M; Chang PP
    Curr Opin Organ Transplant; 2019 Jun; 24(3):233-238. PubMed ID: 31090629
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Moving beyond HLA: a review of nHLA antibodies in organ transplantation.
    Sigdel TK; Sarwal MM
    Hum Immunol; 2013 Nov; 74(11):1486-90. PubMed ID: 23876683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annual literature review of donor-specific HLA antibodies after organ transplantation.
    Kaneku H
    Clin Transpl; 2011; ():311-8. PubMed ID: 22755424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitization and desensitization of burn patients as potential candidates for vascularized composite allotransplantation.
    Klein HJ; Schanz U; Hivelin M; Waldner M; Koljonen V; Guggenheim M; Giovanoli P; Gorantla VS; Fehr T; Plock JA
    Burns; 2016 Mar; 42(2):246-57. PubMed ID: 26392022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Desensitization: achieving immune detente.
    Zachary AA; Eng HS
    Tissue Antigens; 2011 Jan; 77(1):3-8. PubMed ID: 21155718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney transplantation across a positive crossmatch: a single-center experience.
    Santos C; Costa R; Malheiro J; Pedroso S; Almeida M; Martins LS; Dias L; Tafulo S; Henriques AC; Cabrita A
    Transplant Proc; 2014; 46(6):1705-9. PubMed ID: 25131017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Summarizing the use of donor specific anti-HLA antibody monitoring in transplant patients.
    Everly MJ
    Clin Transpl; 2011; ():333-6. PubMed ID: 22755427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Excellent renal allograft survival in donor-specific antibody transplant patients--role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Dhanda R; Shah Y; Bardapure M; Bhattacharjya S; Sharma AK
    Transplantation; 2009 Aug; 88(3):444. PubMed ID: 19667954
    [No Abstract]   [Full Text] [Related]  

  • 35. The presence of donor-specific antibodies in renal transplantation.
    Tozkir H; Sağiroğlu T; Kiliçarslan-Ayna T; Tan S; Çopuroğlu E; Sağiroğlu G; Sari G; Gürkan H; Sezer A
    Transplant Proc; 2012; 44(6):1667-9. PubMed ID: 22841240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney transplant in highly sensitized patients after desensitization with plasmapheresis and low-dose intravenous immunoglobulin.
    Yuan XP; Wang CX; Gao W; Fu Q; He XS
    Exp Clin Transplant; 2010 Jun; 8(2):130-5. PubMed ID: 20565369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact and production of Non-HLA-specific antibodies in solid organ transplantation.
    Zhang X; Reinsmoen NL
    Int J Immunogenet; 2020 Jun; 47(3):235-242. PubMed ID: 32426916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA incompatible renal transplantation.
    Montgomery RA; Warren DS; Segev DL; Zachary AA
    Curr Opin Organ Transplant; 2012 Aug; 17(4):386-92. PubMed ID: 22790073
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
    Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
    Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Sex in the Efficacy of Perioperative Desensitization Procedures in Heart Transplantation: A Retrospective Cohort Study.
    Nguyen LS; Salem JE; Bories MC; Coutance G; Amour J; Bougle A; Suberbielle C; Kheav VD; Carmagnat M; Rouvier P; Kirsch M; Varnous S; Leprince P; Saheb S
    Front Immunol; 2021; 12():659303. PubMed ID: 34305891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.